About Us

Greetings

greeting

Repure Life Science was founded on the premise that it is 'pure' to help people suffering from cancer and disease and furthermore, to make society without disease.

It is a compound word that combines Re, which means 'relax', and Pure, which means 'pure', and implies 'relax'.In general, purity is often used in a positive and hopeful sense of clean, clear, evil, and good.

We are based on this meaning and we are made up of people who have pure passion to give hope and faith in healing to many people. It is about the mindset we have, the ultimate goal we have to achieve, and the purity we seek.We are also convinced that researching and developing therapeutic agents to maximize the influence of purity with effort, passion, and potential is a hope and belief for everyone.

But this is just a small beginning of the influence of pureness in Repure Life Sciences.In the future, we will continue to draw a big picture by believing in the influence of our innocence, and we will continue to move toward our goals with the desire and faith of our patients, the commitment and efforts of medical staff and researchers, and our innocence and enthusiasm so that everyone can live a pure life.

history

History

2020
December2020.12
  • 'Yonsei Medical Center - Repure Life Science' Technology Transfer Contract

    ※ the pharmaceutical composition for prevention or treatment of fibrosis

November2020.11
  • 'Yonsei Medical Center-Repure Life Science-Ewha Womans University-CHA Medical School' technology transfer contract

    ※ Functional Inhibition New Compounds Targeting the Major Causes of Intractable Fibrosis Diseases Proteins

October2020.10
  • 'Repure Life Science - Ewha Womans University College of Pharmacy' Signs Industry-University-Academic Agreement
May2020.05
  • Yonsei Medical Center - Refurbish Life Science - Gyeongnam Biopharma joint research agreement

    Development of Antibody for the Treatment of COVID-19 based on Immunoprotein

January2020.01
  • Jeonbuk TP-PDIGID-Refurbish Life Sciences Signs MOU to Activate Agricultural Life and Biotechnology Industry
2019
October2019.10
  • Cambridge Milner Institute – Yonsei University

    ※ Research Projects to Excavate New Treatment Targets for Intractable Tumors Based on Artificial Intelligence

September2019.09
  • Cleveland Clinic AI New Drug Development & Big Data Joint Research Business Agreement

July2019.07
  • Immune Anti-Cancer Drug Development Starts (3,4 Generations) -2019.07.01

    ※ ‘Refure Life Sciences-Osong Advanced Medical Industry Promotion Foundation New Drug Development Center Contract’

June2019.06
  • Cambridge Milner Institute for AI New Drug Development Joint Research Agreement
May2019.05
  • Selection and Occupation of Osong New Drug Development Laboratory
April2019.04
  • Joint Research and Development on Immune Anti-Cancer Drugs and Contracts for Patent Transfer

    ※ Yonsei University/Medical Center - Asan Medical Center, Seoul - Ulsan University - ETIZEN - Refurbish Life Sciences Co., Ltd.

January2019.01
  • Establishment of Research Institute
2018
December2018.12
  • Change of company name (Repure Bio INC. → Repure Life Science INC.)
November2018.11
  • Signed MOU with 'Repure Bio - Sookmyung Women's University Research & Business Development Foundation'
  • Consultation on technology transfer of new materials for brain cancer
October2018.10
  • Signed MOU with 'Repure Bio - Duksung Innovative Drug Center'
June2018.06
  • Joint research and development related to metabolic anticancer drugs and Signed the technology transfer agreement with priority of metabolic anticancer drugs

    ※ 'Yonsei University - Repure Bio' [Application No. 10-2017-0111840]

May2018.05
  • Establishment of corporation (Repure Bio INC.)
March2018.03
  • Selected and Participated in 'Yonsei Enterprise Support Foundation'